Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy.
Loss
M
M
Klinik für Abdominal und Transplantationschirurgie, Medizinische Hochschule Hannover, Germany.
Winkler
M
M
Schneider
A
A
Oldhafer
K
K
Manns
M P
MP
Pichlmayr
R
R
D001053:Apolipoproteins / Q000097:blood; D001057:Apolipoproteins E / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism*; D002784:Cholesterol / Q000097:blood*; D004359:Drug Therapy, Combination; D005951:Glucose Tolerance Test; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D008074:Lipoproteins / Q000097:blood*; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D011239:Prednisolone / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use*
D001053:Apolipoproteins; D001057:Apolipoproteins E; D001786:Blood Glucose; D007166:Immunosuppressive Agents; D007328:Insulin; D008074:Lipoproteins; D002784:Cholesterol; D011239:Prednisolone; D016559:Tacrolimus